Donepezil, Rivastigmine , Galantamine & Memantine criticized in NICE report
The National Institute for Clinical Excellence (NICE) is part of the National Health Service in the UK. It is the independent organisation responsible for providing national guidance on treatments and care for people using the NHS in England and Wales. The guidance provided is intended for healthcare professionals, patients and their caregivers to help them make decisions about treatment and healthcare.
NICE guidance is developed using the expertise of the NHS and wider healthcare community including NHS staff, healthcare professionals, patients and carers, industry and the academic community.
In their most recent report NICE has come out against some of the most commonly used medications for mild to moderate Alzheimer's, claiming their effects do not warrant the money being spent on them. Readers of the report are invited to comment on each section. After you click on the link below you will need to scroll down a little before the report starts. Click here to view the report
03/01/2005
